Don't Be Surprised to See Additional Meds Used for COVID-19

You'll hear more about using tocilizumab or ivermectin to treat patients hospitalized with COVID-19.

Tocilizumab (Actemra) is an injectable "IL-6 inhibitor" that may help reduce the risk of death in certain COVID-19 inpatients.

But tocilizumab has downsides...such as an increased risk for serious infections and a price tag of up to $4,600/dose.

Get unlimited access through an Enterprise license

Hospital Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals